{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:39:58Z","timestamp":1772134798082,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"DOI":"10.1038\/s41371-024-00968-5","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T06:02:21Z","timestamp":1730440941000},"page":"38-45","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Course of brain damage following malignant hypertension"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5870-7258","authenticated-orcid":false,"given":"Jean Sebastien","family":"Liegey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6197-5766","authenticated-orcid":false,"given":"Antoine","family":"Cremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovic","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Gosse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Debeugny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1246-0712","authenticated-orcid":false,"given":"Sebastien","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Doublet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Sibon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Boulestreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"968_CR1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/ajh\/hpx008","volume":"30","author":"A Shantsila","year":"2017","unstructured":"Shantsila A, Lip GYH. Malignant Hypertension Revisited-Does This Still Exist? Am J Hypertens. 2017;30:543\u20139.","journal-title":"Am J Hypertens"},{"key":"968_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/jhh.2015.112","volume":"30","author":"A Cremer","year":"2016","unstructured":"Cremer A, Amraoui F, Lip GYH, Morales E, Rubin S, Segura J, et al. From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency. J Human Hypertens. 2016;30:463\u20136.","journal-title":"J Human Hypertens"},{"key":"968_CR3","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.amjhyper.2007.02.018","volume":"20","author":"BJH van den Born","year":"2007","unstructured":"van den Born BJH, Koopmans RP, van Montfrans GA. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension. Am J Hypertens. 2007;20:900\u20136.","journal-title":"Am J Hypertens"},{"key":"968_CR4","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1097\/HJH.0000000000001446","volume":"35","author":"A Shantsila","year":"2017","unstructured":"Shantsila A, Shantsila E, Beevers DG, Lip GYH. Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry. J Hypertens. 2017;35:2310\u20134.","journal-title":"J Hypertens"},{"key":"968_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/archinte.1928.00130140003001","volume":"41","author":"NM Keith","year":"1928","unstructured":"Keith NM, Wagener HP. Kernohan JW. The syndrome of malignant hypertension. Arch Internal Med. 1928;41:141\u201388.","journal-title":"Arch Internal Med"},{"key":"968_CR6","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1097\/00004872-199411000-00013","volume":"12","author":"GY Lip","year":"1994","unstructured":"Lip GY, Beevers M, Beevers G. The failure of malignant hypertension to decline: a survey of 24 years\u2019 experience in a multiracial population in England. J Hypertens. 1994;12:1297\u2013305.","journal-title":"J Hypertens"},{"key":"968_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/ehjcvp\/pvy032","volume":"5","author":"BJH van den Born","year":"2019","unstructured":"van den Born BJH, Lip GYH, Brguljan-Hitij J, Cremer A, Segura J, Morales E, et al. ESC Council on hypertension position document on the management of hypertensive emergencies. Eur Heart J Cardiovasc Pharmacother. 2019;5:37\u201346.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"968_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HJH.0000000000001611","volume":"36","author":"S Rubin","year":"2018","unstructured":"Rubin S, Cremer A, Boulestreau R, Rigothier C, Kuntz S, Gosse P. Malignant hypertension: diagnosis, treatment and prognosis with experience from the Bordeaux cohort. J Hypertens. 2018;36:1\u20139.","journal-title":"J Hypertens"},{"key":"968_CR9","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1097\/HJH.0000000000002950","volume":"39","author":"R Boulestreau","year":"2021","unstructured":"Boulestreau R, Lucas L, Cremer A, Debeugny S, Rubin S, Gaudissard J, et al. Neurologically asymptomatic patients frequently present cerebral injuries during malignant hypertension: a MRI study. J Hypertens. 2021;39:2463\u20139.","journal-title":"J Hypertens"},{"key":"968_CR10","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","volume":"36","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953\u20132041.","journal-title":"J Hypertens"},{"key":"968_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0140-6736(00)02539-3","volume":"356","author":"CJ Vaughan","year":"2000","unstructured":"Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet. 2000;356:411\u20137.","journal-title":"Lancet"},{"key":"968_CR12","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JBAA. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. AJR. Am J Roentgenol. 1987;149:351\u20136.","journal-title":"Am J Roentgenol"},{"key":"968_CR13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3174\/ajnr.A2366","volume":"32","author":"YC Zhu","year":"2011","unstructured":"Zhu YC, Dufouil C, Mazoyer B, Soumar\u00e9 A, Ricolfi F, Tzourio C, et al. Frequency and location of dilated Virchow-Robin spaces in elderly people: A population-based 3D MR imaging study. Am J Neuroradiol. 2011;32:709\u201313.","journal-title":"Am J Neuroradiol"},{"key":"968_CR14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822\u201338.","journal-title":"Lancet Neurol"},{"key":"968_CR15","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1212\/WNL.0000000000000837","volume":"83","author":"J Staals","year":"2014","unstructured":"Staals J, Makin SDJ, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83:1228\u201334.","journal-title":"Neurology"},{"key":"968_CR16","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.lpm.2019.09.060","volume":"48","author":"T Denolle","year":"2019","unstructured":"Denolle T, Asmar R, Boivin JM, Girerd X, Le Jeune S, Vaisse B, et al. Recommandations sur la mesure de la pression art\u00e9rielle. Consensus d\u2019experts de la Soci\u00e9t\u00e9 fran\u00e7aise d\u2019hypertension art\u00e9rielle, filiale de la Soci\u00e9t\u00e9 fran\u00e7aise de cardiologie. La Presse M\u00e9dicale. 2019;48:1319\u201328.","journal-title":"La Presse M\u00e9dicale"},{"key":"968_CR17","doi-asserted-by":"publisher","first-page":"e2454","DOI":"10.1212\/WNL.0000000000201205","volume":"99","author":"ACC Jochems","year":"2022","unstructured":"Jochems ACC, Arteaga C, Chappell F, Ritakari T, Hooley M, Doubal F, et al. Longitudinal Changes of White Matter Hyperintensities in Sporadic Small Vessel Disease: A Systematic Review and Meta-analysis. Neurology. 2022;99:e2454\u201363.","journal-title":"Neurology"},{"key":"968_CR18","doi-asserted-by":"publisher","first-page":"c3666","DOI":"10.1136\/bmj.c3666","volume":"341","author":"S Debette","year":"2010","unstructured":"Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666.","journal-title":"BMJ"},{"key":"968_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-13-71","volume":"13","author":"F Amraoui","year":"2012","unstructured":"Amraoui F, Bos S, Vogt L, van den Born BJ. Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study. BMC Nephrol. 2012;13:71.","journal-title":"BMC Nephrol"},{"key":"968_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.691244","volume":"15","author":"M Bretzner","year":"2021","unstructured":"Bretzner M, Bonkhoff AK, Schirmer MD, Hong S, Dalca AV, Donahue KL, et al. MRI Radiomic Signature of White Matter Hyperintensities Is Associated With Clinical Phenotypes. Front Neurosci. 2021;15:691244.","journal-title":"Front Neurosci"},{"key":"968_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-021-02140-9","volume":"21","author":"ZG Min","year":"2021","unstructured":"Min ZG, Shan HR, Xu L, Yuan DH, Sheng XX, Xie WC, et al. Diffusion tensor imaging revealed different pathological processes of white matter hyperintensities. BMC Neurol. 2021;21:128.","journal-title":"BMC Neurol"},{"key":"968_CR22","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1161\/STROKEAHA.119.027544","volume":"51","author":"NJ Armstrong","year":"2020","unstructured":"Armstrong NJ, Mather KA, Sargurupremraj M, Knol MJ, Malik R, Satizabal CL, et al. Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities. Stroke. 2020;51:2111\u201321.","journal-title":"Stroke"},{"key":"968_CR23","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/HYP.0000000000000053","volume":"68","author":"C Iadecola","year":"2016","unstructured":"Iadecola C, Yaffe K, Biller J, Bratzke LC, Faraci FM, Gorelick PB, et al. Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association. Hypertension. 2016;68:e67\u201394.","journal-title":"Hypertension"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-024-00968-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-024-00968-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-024-00968-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T19:02:42Z","timestamp":1736449362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-024-00968-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["968"],"URL":"https:\/\/doi.org\/10.1038\/s41371-024-00968-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4355241\/v1","asserted-by":"object"}]},"ISSN":["1476-5527"],"issn-type":[{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"assertion":[{"value":"1 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}